Neurodegenerative Diseases
Neurodegenerative diseases are a group of conditions characterized by progressive damage to nerve cells in the brain, spinal cord, or peripheral nervous system. As the disease progresses, nerve cells gradually lose their ability to function, connections between them are damaged, and some cells die. Because many nerve cells have a limited ability to regenerate, the accumulating damage can lead to lasting impairments in essential functions, including memory, thinking, movement, speech, and swallowing.
The best-known neurodegenerative diseases are Alzheimer’s and Parkinson’s. Alzheimer’s disease primarily affects memory and thinking, while Parkinson’s disease is characterized by movement problems, including tremor, muscle stiffness, and slowness of movement. Other diseases in this group include amyotrophic lateral sclerosis (ALS), which damages the nerve cells responsible for activating muscles, and Huntington’s disease, an inherited condition that affects movement, thinking, and behavior. Although these diseases have different characteristics, they all involve the gradual degeneration of nerve cells.
The mechanisms that cause nerve cell degeneration are complex and still not fully understood. In Alzheimer’s disease, for example, amyloid-beta and tau proteins accumulate in the brain, while Parkinson’s disease involves an abnormal buildup of the protein alpha-synuclein. Proteins that do not fold correctly or are not properly cleared can accumulate and disrupt cell function. Other mechanisms involved in these diseases include damage to mitochondria (the organelles that produce usable energy for cells), inflammation, and disruptions to cellular waste disposal systems. Risk factors vary by disease and include age, genetic changes, and sometimes environmental factors.
Most neurodegenerative diseases still have no cure, but treatments can relieve symptoms and, for some diseases, may also slow progression. Research focuses on detecting degeneration early, understanding the mechanisms that damage nerve cells, and developing treatments that target them. A study by Dr. Ronit Ilouz and her colleagues at the Dangoor Center for Personalized Medicine at Bar-Ilan University examined a rare neurodegenerative disease caused by a genetic change affecting the protein PKA. The researchers found that mice carrying this change developed abnormal protein aggregates at a young age, before motor symptoms appeared. They also identified a mechanism that reduced protein accumulation under the conditions tested, a finding that could help guide the development of future treatments.
Frequently asked questions
1. What are neurodegenerative diseases?
Neurodegenerative diseases are conditions in which nerve cells are gradually damaged and lose their ability to function. Because nerve cells transmit information and coordinate the body’s activities, this damage can affect memory, thinking, movement, and other functions. Common diseases in this group include Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Huntington’s disease.
2. What are the early signs of neurodegenerative diseases?
The signs vary by disease. Alzheimer’s may cause problems with memory and orientation, Parkinson’s may cause tremor or slowness of movement, and ALS may cause progressive muscle weakness. Some diseases also involve changes in sleep, speech, or behavior. These symptoms can result from other medical conditions, so their presence does not necessarily indicate a neurodegenerative disease.
3. Are neurodegenerative diseases inherited?
Some of these diseases have a strong genetic component. Huntington’s disease, for example, is caused by a change in a specific gene and is inherited. By contrast, most cases of Alzheimer’s and Parkinson’s are not caused by a single genetic change passed down through a family. However, changes in certain genes can increase the risk of developing these diseases, alongside other factors.
4. Are neurodegenerative diseases a natural part of aging?
No. Normal aging can involve some changes in memory and the speed at which information is processed, but neurodegenerative diseases involve pathological processes that damage nerve cells. The risk of some of these diseases, particularly Alzheimer’s and Parkinson’s, increases significantly with age, but they can also develop in younger people.
5. How are neurodegenerative diseases diagnosed?
Diagnosis is based on symptoms, medical history, and a neurological examination. It may also involve cognitive testing, brain imaging, and genetic testing. For some diseases, biomarkers, biological indicators of disease-related processes, can help with diagnosis. For example, cerebrospinal fluid tests and certain blood tests may help diagnose Alzheimer’s disease. The choice of tests depends on the suspected disease.
6. What is the difference between dementia and a neurodegenerative disease?
Dementia is a syndrome involving a decline in thinking, memory, or language abilities severe enough to interfere with daily life. Neurodegenerative diseases are a broad group of conditions that damage nerve cells. Alzheimer’s is a neurodegenerative disease that causes dementia, but some neurodegenerative diseases primarily cause movement problems. Dementia can also result from damage to blood vessels in the brain and other causes.
7. Can neurodegenerative diseases be treated?
Medications and rehabilitation therapies can help relieve symptoms and improve quality of life. For some diseases, treatments also aim to slow deterioration. For example, biological therapies targeting amyloid-beta may modestly slow the progression of early-stage Alzheimer’s in suitable patients, but they carry risks and require medical monitoring. Treatment effectiveness depends on the disease and the stage at which it is diagnosed.
8. Can neurodegenerative diseases be prevented?
There is currently no proven way to prevent all neurodegenerative diseases. However, research suggests that regular physical activity, avoiding smoking, managing blood pressure and blood sugar levels, and treating hearing loss may reduce the risk of developing dementia. The evidence relates mainly to dementia, and it remains unclear how much these measures might reduce the risk of other neurodegenerative diseases.
Last Updated Date : 16/11/2026